Quick Takeaways
- Matthew C. Hill has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $9,605.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Matthew C. Hill and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| APYX | Apyx Medical Corp | Chief Financial Officer | $9,605 | 15 May 2025 | ||
| PDSB | PDS Biotechnology Corp | Chief Financial Officer | 05 Jan 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|